7AA08B08-B1DD-47AB-A0F2-850F6DE95093
—
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- —
- cancer_type_detailed
- —
- subtype
- —
- overall_survival_months
- 20.466491458607095
- age_years
- 40
- sex
- Male
GSVA pathway preview (0 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
10 twins match this tumor's tissue · 0 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | 65F93AB7-AA99-49B5-8D59-7D0DE9CA9E34 | — | — | 0.962 |
| 2 | DC01D165-E257-49D6-8B9B-37CA7DE398F6 | — | — | 0.956 |
| 3 | SRR934949 | — | — | 0.952 |
| 4 | 795FBB8C-0E74-477F-AA27-1CE97A4E90B9 | — | — | 0.952 |
| 5 | A678E1E5-E02D-49A1-BB2B-C91A60E6382E | — | — | 0.952 |
| 6 | D494D692-9EC2-429A-A0FE-696D2A152D4A | — | — | 0.950 |
| 7 | B27956E8-3374-4720-9F80-7CE6FE7C7690 | — | — | 0.948 |
| 8 | D5191F3D-028E-401C-927E-483F6884BE39 | — | — | 0.946 |
| 9 | SRR934961 | — | — | 0.946 |
| 10 | 7876A884-F031-42AB-ADC0-89589760FB6B | — | — | 0.945 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 42 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| TGF_BETA_SIGNALING | 0.477 | Inavolisib | — uncovered |
| MYC_TARGETS_V1 | 0.458 | Inavolisib | — uncovered |
| MYC_TARGETS_V2 | 0.458 | Idelalisib | — uncovered |
| DNA_REPAIR | 0.453 | Idelalisib | — uncovered |
| TNFA_SIGNALING_VIA_NFKB | 0.443 | Inavolisib | — uncovered |
| E2F_TARGETS | 0.436 | Inavolisib | — uncovered |
| INTERFERON_ALPHA_RESPONSE | 0.420 | Inavolisib | — uncovered |
| G2M_CHECKPOINT | 0.418 | Inavolisib | — uncovered |
| IL6_JAK_STAT3_SIGNALING | 0.405 | Inavolisib | — uncovered |
| UNFOLDED_PROTEIN_RESPONSE | 0.392 | Idelalisib | — uncovered |
| ALLOGRAFT_REJECTION | 0.387 | Idelalisib | — uncovered |
| INTERFERON_GAMMA_RESPONSE | 0.379 | Idelalisib | — uncovered |
| NOTCH_SIGNALING | 0.346 | Inavolisib | — uncovered |
| PROTEIN_SECRETION | 0.343 | Remibrutinib | — uncovered |
| PI3K_AKT_MTOR_SIGNALING | 0.329 | Inavolisib | — uncovered |
| MITOTIC_SPINDLE | 0.327 | Inavolisib | — uncovered |
| WNT_BETA_CATENIN_SIGNALING | 0.320 | Inavolisib | — uncovered |
| APOPTOSIS | 0.315 | Idelalisib | — uncovered |
| ANDROGEN_RESPONSE | 0.301 | Inavolisib | — uncovered |
| ANGIOGENESIS | 0.299 | Remibrutinib | — uncovered |